Evaluating the efficacy of percutaneous nephrostomy in managing hematuria following antegrade double j ureteral stent placement

Muhammet Arslan, H. Aslan, Burak Kurnaz, Kadirhan Alver, Mahmut Demirci, Mehmet Alpua, S. Çelen
{"title":"Evaluating the efficacy of percutaneous nephrostomy in managing hematuria following antegrade double j ureteral stent placement","authors":"Muhammet Arslan, H. Aslan, Burak Kurnaz, Kadirhan Alver, Mahmut Demirci, Mehmet Alpua, S. Çelen","doi":"10.31362/patd.1501235","DOIUrl":null,"url":null,"abstract":"Purpose: This study aims to evaluate the clinical outcomes of percutaneous nephrostomy in patients who develop hematuria during percutaneous antegrade double j stent placement. \nMaterials and methods: We conducted a multicenter retrospective cross-sectional study, reviewing medical records from January 2016 to June 2024, to identify patients who underwent percutaneous antegrade double j stent placement and developed hematuria. Percutaneous antegrade double j stent and nephrostomy procedures were performed under ultrasound and fluoroscopic guidance. \nResults: The study included 151 patients with a mean age of 65.9 ± 15.3 years; 46 (30.5%) were female, and 105 (69.5%) were male. Hematuria was observed in 20 (8.9%) of the 225 antegrade double j stent procedures. Hematuria was significantly more common in patients with benign conditions (35%) compared patients with malignant tumors (9.2%) (p=0.003). Postoperative nephrostomy was performed in 118 (52.4%) of the procedures. Among patients who developed hematuria, 11 (55%) received a nephrostomy, compared to 9 (45%) without hematuria, though this difference was not statistically significant (p=0.811). \nConclusion: Percutaneous nephrostomy appears to be an effective intervention for managing hematuria in patients undergoing antegrade double j stent placement. However, the study did not find a statistically significant difference in hematuria incidence with nephrostomy placement, indicating the need for further research with larger sample sizes to confirm these findings and optimize postoperative management strategies.","PeriodicalId":506150,"journal":{"name":"Pamukkale Medical Journal","volume":"731 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pamukkale Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31362/patd.1501235","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This study aims to evaluate the clinical outcomes of percutaneous nephrostomy in patients who develop hematuria during percutaneous antegrade double j stent placement. Materials and methods: We conducted a multicenter retrospective cross-sectional study, reviewing medical records from January 2016 to June 2024, to identify patients who underwent percutaneous antegrade double j stent placement and developed hematuria. Percutaneous antegrade double j stent and nephrostomy procedures were performed under ultrasound and fluoroscopic guidance. Results: The study included 151 patients with a mean age of 65.9 ± 15.3 years; 46 (30.5%) were female, and 105 (69.5%) were male. Hematuria was observed in 20 (8.9%) of the 225 antegrade double j stent procedures. Hematuria was significantly more common in patients with benign conditions (35%) compared patients with malignant tumors (9.2%) (p=0.003). Postoperative nephrostomy was performed in 118 (52.4%) of the procedures. Among patients who developed hematuria, 11 (55%) received a nephrostomy, compared to 9 (45%) without hematuria, though this difference was not statistically significant (p=0.811). Conclusion: Percutaneous nephrostomy appears to be an effective intervention for managing hematuria in patients undergoing antegrade double j stent placement. However, the study did not find a statistically significant difference in hematuria incidence with nephrostomy placement, indicating the need for further research with larger sample sizes to confirm these findings and optimize postoperative management strategies.
评估经皮肾造瘘术在处理前行双 J 输尿管支架置入术后血尿的疗效
目的:本研究旨在评估经皮肾造瘘术对在经皮前路双 J 支架置入过程中出现血尿的患者的临床疗效。材料与方法:我们进行了一项多中心回顾性横断面研究,回顾了 2016 年 1 月至 2024 年 6 月的病历,以确定接受经皮前路双 J 支架置入术并出现血尿的患者。经皮前路双 J 支架和肾造瘘术均在超声和透视引导下进行。研究结果研究共纳入 151 名患者,平均年龄(65.9±15.3)岁;其中 46 名(30.5%)为女性,105 名(69.5%)为男性。在 225 例前向双 J 支架手术中有 20 例(8.9%)观察到血尿。与恶性肿瘤患者(9.2%)相比,良性疾病患者(35%)出现血尿的比例明显更高(P=0.003)。118例(52.4%)手术中进行了术后肾造瘘术。在出现血尿的患者中,有 11 人(55%)接受了肾造瘘术,而没有血尿的患者有 9 人(45%)接受了肾造瘘术,但这一差异没有统计学意义(P=0.811)。结论经皮肾造瘘术似乎是控制前行双 J 支架置入术患者血尿的有效干预措施。然而,该研究并未发现肾造瘘术与血尿发生率之间存在统计学意义上的显著差异,这表明需要进一步开展样本量更大的研究,以证实这些发现并优化术后管理策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信